前往化源商城

Urologic nursing : official journal of the American Urological Association Allied 2013-01-01

Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer.

Neal D Shore, Paul Sieber, Leanne Schimke, Adam Perzin, Scott Olsen

文献索引:Urol. Nurs. 33(5) , 236-44, 248, (2013)

全文:HTML全文

摘要

This multicenter, randomized, crossover, open-label study (ClinicalTrials.gov identifier: NCT01161563) assessed patients'and clinicians'perceptions of injection site tolerability and adverse events following the intramuscular injection of triptorelin pamoate or subcutaneous injection of leuprolide acetate in 107 male, patients with advanced prostate cancer.

相关化合物

结构式 名称/CAS号 全部文献
亮丙瑞林 结构式 亮丙瑞林
CAS:53714-56-0
曲普瑞林 结构式 曲普瑞林
CAS:57773-63-4
黄体生成激素释放激素(LHRH) 结构式 黄体生成激素释放激素(LHRH)
CAS:33515-09-2
醋酸亮丙瑞林 结构式 醋酸亮丙瑞林
CAS:74381-53-6